期刊文献+

系统性红斑狼疮患者CD62P、CD63表达与SLEDAI相关性分析 被引量:1

Expression of CD62P and CD63 in patients with systemic lupus erythematosus and their correlation with SLEDAI
下载PDF
导出
摘要 目的:观察系统性红斑狼疮(SLE)患者外周血血小板膜蛋白CD62P、CD63的表达,并探讨CD62P、CD63与SLE疾病活动指数(SLEDAI)之间的相关性。方法:采用流式细胞术对10例SLE患者外周血CD62P、CD63进行检测分析,以20例正常人作为对照。同时对该10例SLE患者进行SLEDAI评分。结果:SLE患者CD62P、CD63表达较对照组显著增高(P<0.01),CD62P表达与SLEDAI之间具有显著相关性(r=0.840,P=0.002)。结论:CD62P、CD63在SLE患者外周血中表达显著增高,CD62P可作为评估SLE疾病活动程度指标。 Objective: To measure the expression of platelet membrane proteins (CD62P and CD63) of peripheral blood in patients with systemic lupus erythematosus (SLE) and to assess their correlation with SLEDAI. Methods: The expressions of CD62P and CD63 in 10 SLE cases and 20 healthy volusiteers were measured by flow cytometry (FCM), and the results were compared with SLEDAI score. Results: The expressions of CD62P and CD63 were significantly higher in SLE than those in health) volunteers ( P 〈 0.01 ). CD62P was positively correlated with SLEDAI score (P 〈 0.05 ). Conclusion: The expressions of CD62P and CD63 in peripheral blood were significantly higher in patients with SLE and CD62P can be regaMed as an in,heator in evaluating the activity of SLE.
出处 《中国麻风皮肤病杂志》 2006年第3期185-186,共2页 China Journal of Leprosy and Skin Diseases
关键词 系统性红斑狼疮 CD62P CD63 流式细胞术 SLE疾病活动指数 systemic lupus erythematosus CD62P CD63 flow cytometry SLEDAI
  • 相关文献

参考文献4

二级参考文献3

  • 1[1]Tschoepe D.The activated megakaryocyte-platelet-system in vascular disease:focus in diabetes[J].Se min Thromb He most,1995,21:152~162.
  • 2[2]Oda T,Kimura M,Khishida A,et al.Cell-cell interacrion is required to induce Proteinuria nin situ immune complex glomerulone-pritis[J].Lab Clin Med,1998,132:112~123.
  • 3姜兆顺,张胜兰,晏辉,邢万佳.Ⅱ型糖尿病微血管病变患者的血小板活化研究[J].中国现代医学杂志,1999,9(8):17-17. 被引量:6

共引文献1

同被引文献16

  • 1Mininkova AI. Platelet structure and functions. ( a review of literature). Part 1. Klin Lab Diagn,2010,12 : 21-26.
  • 2Serebruany V,Malinin A,Aradi D,et al. The in vitro effects of niacin on platelet biomarkers in human volunteers. Thromb Haemost, 2010, 104: 311-317.
  • 3Nekludov M, Bellander BM, Blomback M, et al. Platelet dysfunction in patients with severe traumatic brain injury. Neurotrauma,2007,24:1699- 1706.
  • 4Haas S, Walenga JM, Jeske UP, et al. Heparin-induced thrombocytope- nia:the role plateletactivation and therapeutic implication. Semin Thromb Hemost, 1999,25:67-75.
  • 5Sedlmayr P, Grobhaupt B, Muntean W. Flow cytometry detection of intra- cellular platelet antigens. Cytometry, 1996,23:284-289.
  • 6Shimohina NY, Petrova MM, Savchenko AA, et al. Platelet aggregation and endothelial function in patients with complicated essential hyperten- sion (ischemic stroke) and coronary heart disease. Bull Exp Biol Med, 2010,149 : 18-20.
  • 7Kleinschnitz C, De Meyer SF, Schwarz T, et al. Deficiency of yon Wille- brand factor protects mice from isehemic stroke. Blood,2009,113:3600- 3603.
  • 8Peeerschke EI, Yin W, Ghebrehiwet B. Complement activation on plate- lets:implications for vascular inlammation and thrombosis. Mol Immunol,2010,47:2170-2175.
  • 9Bae ON, Kim YD, Lim KM, et al. Salsolinol, an endogenous neurotoxin, enhances platelet aggregation and thrombus formation. Thromb Haemost, 2008,100:52-59.
  • 10Seizer P, Gawaz M, May AE. Platelet-monocyte interactions-a dangerous liaison linking thrombosis, inflammation and atheroosclerosis. Curr Med Chem,2008,15 : 1976-1980.

引证文献1

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部